Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type

Prosthesis choice during aortic valve replacement (AVR) weighs lifelong anticoagulation with mechanical valves (M-AVR) against structural valve degeneration in bioprosthetic valves (B-AVR). The Nationwide Readmissions Database was queried to identify patients who underwent isolated surgical AVR betw...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of surgical research 2023-07, Vol.287, p.124-133
Main Authors: Sylvester, Christopher B., Ryan, Christopher T., Frankel, William C., Zea-Vera, Rodrigo, Zhang, Qianzi, Wall, Matthew J., Moon, Marc R., Coselli, Joseph S., Rosengart, Todd K., Chatterjee, Subhasis, Ghanta, Ravi K.
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Aortic Valve - surgery
Aortic valve replacement
Bioprosthesis
Bioprosthetic valve
Heart Valve Prosthesis Implantation - adverse effects
Humans
Mechanical valve
Outcomes
Patient Readmission
Propensity score matching
Prosthesis Design
Readmissions
Retrospective Studies
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prosthesis choice during aortic valve replacement (AVR) weighs lifelong anticoagulation with mechanical valves (M-AVR) against structural valve degeneration in bioprosthetic valves (B-AVR). The Nationwide Readmissions Database was queried to identify patients who underwent isolated surgical AVR between January 1, 2016 and December 31, 2018, stratifying by prothesis type. Propensity score matching was used to compare risk-adjusted outcomes. Readmission at 1 y was estimated with Kaplan–Meier (KM) analysis. Patients (n = 109,744) who underwent AVR (90,574 B-AVR and 19,170 M-AVR) were included. B-AVR patients were older (median 68 versus 57 y; P 
ISSN:0022-4804
1095-8673
1095-8673
DOI:10.1016/j.jss.2023.01.007